711 
Interleukin-27, a Novel Anti-HIV Cytokine, Inhibits HIV-1 Replication in Macrophages with the Activation of Multiple Interferon-inducible Genes
Terrence Brann*1, J Yang1, D W Huang1, B Fullmer1, J Adelsberger1, R Lempicki1, M Baseler1, C Lane2, and T Imamichi1
1SAIC-Frederick, MD, US and 2NIAID, NIH, Bethesda, MD, US
Background: We have previously identified that interleukin
(IL) -27, a member of the IL-12 cytokine family, is a novel anti-HIV cytokine.
Like interferon (IFN) -α, IL-27 inhibits HIV-1 replication in both CD4+
T cells and monocyte-derived macrophages (MDM). To elucidate the mechanism of
the antiviral activity, we compared the antiviral effect and gene expression
profile of IL-27-treated cells to those of IFN-α-treated cells.
Methods: CD4+ T cells and monocytes were
isolated from healthy donors’ peripheral blood mononuclear cells (PBMC). CD4+
T cells were stimulated with phytohemagglutinin (PHA), and MDM were induced
from monocytes using macrophage-colony stimulating factor. CD4+ T
cells and MDM were infected with HIVNL4.3 and HIVAd8,
respectively. HIV-1 replication was monitored by p24 antigen capture assay.
Real-time polymerase chain reaction (RT-PCR) and enzyme-linked immunosorbent
assay (ELISA) were performed to quantitate the production of IFN-α, -β,
and -γ. To determine the role of IFN in the IL-27-mediated HIV inhibition,
a neutralization assay was performed using neutralization antibody. The gene
expression profiles were analyzed using DNA microarray analysis. The gene
expression was confirmed by the Quantigene plex assay.
Results: Both IFN-α and IL-27 preferentially
inhibited HIV-1 replication in MDM compared to CD4+ T cells. The IC50
of IL-27 to CD4+ T cells and MDM was 15±10 ng/mL and 0.4±0.15 ng/mL,
respectively. The quantitative RT-PCR and ELISA indicated that IL-27 had no effect
on the induction of IFN from both cell types, and the neutralization assay
demonstrated that IFN had no significant effect on the IL-27–-mediated
HIV inhibition in both cell types. DNA microarray analysis illustrated that
IL-27 induced 28 IFN-inducible genes (IFIG) in MDM, and 5 IFIG in CD4+
T cells. The overall gene expression profile of IL-27-treated CD4+ T
cells significantly differs from that of IL-27-treated MDM. The quantitative
assay confirmed that IL-27 activated IFIG and genes encoding anti-viral
proteins, e.g., RNA-dependent kinase, oligoadenylate synthetase, myxovirus
protein, and APOBEC3G.
Conclusions: IL-27 preferentially inhibited HIV-1
replication in MDM compared to CD4+ T cells. The cytokine differentially
regulates the gene expression between CD4+ T cells and MDMs. IL-27
significantly induces IFIG and anti-viral genes in MDM as IFN-α does,
suggesting that IL-27 inhibits HIV replication in MDM via mechanism(s) similar
to that of IFN-α; however, the cytokine inhibits the viral replication in
CD4+ T cells via different mechanism(s) compared to MDM.
|